2677 — Distinct Healthcare Holdings Income Statement
0.000.00%
- HK$2.26bn
- HK$5.16bn
- CNY1.06bn
Annual income statement for Distinct Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 473 | 690 | 959 | 1,065 |
| Cost of Revenue | ||||
| Gross Profit | 473 | 690 | 226 | 267 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 182 | 200 | 1,005 | 1,037 |
| Operating Profit | 292 | 490 | -46.9 | 27.8 |
| Total Net Non Operating Interest Income / Expense | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 190 | 195 | 79.7 | 136 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 208 | 204 | 80.2 | 131 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 214 | 206 | 83.8 | 135 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | 214 | 206 | -45 | 16.9 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 3.22 | 3.35 | -0.478 | 0.329 |